Glenn P Wedeen Md A Medical Corporation is categorized under Doctors in Monrovia, CA and active since 2006.
Glenn P Wedeen Md A Medical Corporation was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Glenn P Wedeen at the company’s single location by writing to 540 Cloverleaf Drive, Monrovia, California CA 91016 or by phoning (626) 357-8535. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Glenn P Wedeen Md A Medical Corporation |
| Contact Person: | Glenn P Wedeen |
| Address: | 540 Cloverleaf Drive, Monrovia, California 91016 |
| Phone Number: | (626) 357-8535 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Glenn P Wedeen Md A Medical Corporation was started in 2006 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Glenn P Wedeen for inquiries that concern Glenn P Wedeen Md A Medical Corporation by calling the company number (626) 357-8535, as your correspondence is most welcome. Additionally, the physical location of the single location of Glenn P Wedeen Md A Medical Corporation can be found at the coordinates 34.162098,-118.007913 as well as the street address 540 Cloverleaf Drive in Monrovia, California 91016.
For its online presence, you may visit Glenn P Wedeen Md A Medical Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.